Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival von Starlets, Diana, Gore, Yael, Binsky, Inbal, Haran, Michal, Harpaz, Nurit, Shvidel, Lev, Becker-Herman, Shirly, Berrebi, Alain, Shachar, Idit

Volltext

IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival von Binsky, Inbal, Haran, Michal, Starlets, Diana, Gore, Yael, Lantner, Frida, Harpaz, Nurit, Leng, Lin, Goldenberg, David M, Shvidel, Lev, Berrebi, Alain, Bucala, Richard, Shachar, Idit

Volltext

Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity von Buzaglo-Azriel, Liat, Kuperman, Yael, Tsoory, Michael, Zaltsman, Yehudit, Shachnai, Liat, Zaidman, Smadar Levin, Bassat, Elad, Michailovici, Inbal, Sarver, Alona, Tzahor, Eldad, Haran, Michal, Vernochet, Cecile, Gross, Atan

Volltext

Loss of Muscle MTCH2 Increases Whole-Body Energy Utilization and Protects from Diet-Induced Obesity von Buzaglo-Azriel, Liat, Kuperman, Yael, Tsoory, Michael, Zaltsman, Yehudit, Shachnai, Liat, Zaidman, Smadar Levin, Bassat, Elad, Michailovici, Inbal, Sarver, Alona, Tzahor, Eldad, Haran, Michal, Vernochet, Cecile, Gross, Atan

Volltext

SFEMG: The true value of the negative predictive value von Haran, Michal

Volltext

Balancing glycolysis and mitochondrial OXPHOS: lessons from the hematopoietic system and exercising muscles von Haran, Michal, Gross, Atan

Volltext

Muscle strength and fatigue in patients with generalized myasthenia gravis von Haran, Michal

Volltext

Unbalanced protein S deficiency due to warfarin treatment as a possible cause for thrombosis von Haran, Michal Z., Lichman, Inna, Berebbi, Alain, Weinmann, Eran, Rosenberg, Nurit

Volltext

In response to “current approach to seronegative myasthenia” by Z. Argov von Haran, Michal

Volltext

Impact of Folinic Acid Dosing on Efficacy and Toxicity of High-Dose Methotrexate in Central Nervous System Lymphoma von Haran, Arnon, Even-Zohar, Noa Gross, Haran, Michal, Lebel, Eyal, Aumann, Shlomzion, Shaulov, Adir, Gatt, Moshe, Nachmias, Boaz

Volltext

Predictive Factors to Hypogammaglobulinemia and Non-Neutropenic Infection Complications after Rituximab/Chemotherapy Treatment von Filanovsky, Kalman, Shvidel, Lev, Shtalrid, Mordechai, Haran, Michal, Duek, Adrian, Berrebi, Alain

Volltext

Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we over-treating our patients? von Vardi, Moshe, Haran, Michal

Volltext

The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74 von Cohen, Sivan, Shoshana, Or-yam, Zelman-Toister, Einat, Maharshak, Nitsan, Binsky-Ehrenreich, Inbal, Gordin, Maya, Hazan-Halevy, Inbal, Herishanu, Yair, Shvidel, Lev, Haran, Michal, Leng, Lin, Bucala, Richard, Harroch, Sheila, Shachar, Idit

Volltext

On the clinical encounter with 'zebras' – the science and art of rare diseases von Haran, Michal, Schattner, Ami

Volltext

A phase I‐II clinical trial of the anti‐CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach von Haran, Michal, Mirkin, Vita, Braester, Andrei, Harpaz, Nurith, Shevetz, Olga, Shtreiter, Marina, Greenberg, Shulamit, Mordich, Orly, Amram, Orna, Binsky‐Ehrenreich, Inbal, Marom, Ayelet, Shachar, Idit, Herishanu, Yair, Ruchlemer, Rosa, Berrebi, Alain, Valinsky, Liora, Shtalrid, Mordechai, Shvidel, Lev

Volltext

Clinical Benefit and Improvement of Mitochondrial Function in Low Risk Myelodysplastic Syndrome Treated By Combination Ultra Coenzyme Q10 and L-Carnitine von Filanovsky, Kalman, Haran, Michal, Mirkin, Vita, Braester, Andrei, Shvetz, Olga, Stanevsky, Anfisa, Sigler, Erica, Votinov, Ekaterina, Zaltsman-Amir, Yehudit, Gross, Atan, Shvidel, Lev

Volltext

5.18 Milatuzumab as a Single Agent in Refractory Chronic Lymphocytic Leukemia: Interim Results of a Phase 1–2 Study and Future Plans von Haran, Michal, Berrebi, Alain

Volltext

CD84 is a survival receptor for CLL cells von Binsky-Ehrenreich, I, Marom, A, Sobotta, M C, Shvidel, L, Berrebi, A, Hazan-Halevy, I, Kay, S, Aloshin, A, Sagi, I, Goldenberg, D M, Leng, L, Bucala, R, Herishanu, Y, Haran, M, Shachar, I

Volltext

A phase I‐ II clinical trial of the anti‐ CD 74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach von Haran, Michal, Mirkin, Vita, Braester, Andrei, Harpaz, Nurith, Shevetz, Olga, Shtreiter, Marina, Greenberg, Shulamit, Mordich, Orly, Amram, Orna, Binsky‐Ehrenreich, Inbal, Marom, Ayelet, Shachar, Idit, Herishanu, Yair, Ruchlemer, Rosa, Berrebi, Alain, Valinsky, Liora, Shtalrid, Mordechai, Shvidel, Lev

Volltext

Randomized Trial of Thymectomy in Myasthenia Gravis von Milinis, Kristijonas, Shrager, Joseph B, Haran, Michal, Starobin, Daniel, Schlesinger, Ilana, Wolfe, Gil I, Kaminski, Henry J, Cutter, Gary R

Volltext